Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: Better response in patients under 26 years old

British Journal of Dermatology

Volumn 158, Issue 5, 2008, Pages 1121-1124

  Camacho, F M ^a   Garcia Hernandez M J ^a   Fernandez Crehuet J L ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Finasteride; Male androgenetic alopecia

Indexed keywords

ANDROSTANOLONE; ANDROSTENEDIONE; FINASTERIDE; HYDROXYPROGESTERONE; MINOXIDIL; PRASTERONE SULFATE; PROSTATE SPECIFIC ANTIGEN; STEROID 5ALPHA REDUCTASE INHIBITOR; STEROID HORMONE; TESTOSTERONE;

ADULT; ARTICLE; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG RESPONSE; HAIR GROWTH; HAMILTON NORWOOD SCALE; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; SEBUM; SEBUM SECRETION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TRICHOGRAM;

ADOLESCENT; ADULT; AGE FACTORS; ALOPECIA; DIHYDROTESTOSTERONE; ENZYME INHIBITORS; FINASTERIDE; HAIR; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; SEBUM;

EID: 42049092149     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08509.x     Document Type: Article

References (12)

1. Schmidt JB, Lindmaier A, Spona J. Hormonal parameters in androgenetic hair loss in the male. Dermatologica 1991 182 : 214 17.
2. Drake L, Hordinsky M, Fiedler V et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol 1999 41 : 550 4.
3. Shapiro J, Kaufman KD. Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss). J Invest Dermatol Symp Proc 2003 8 : 20 3.
4. Kaufman K, Olsen E, Whiting D et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998 39 : 578 89.
5. Leyden J, Dunlap F, Miller B et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol 1999 40 : 930 7.
6. Kaufman KD. Finasteride, 1 mg (Propecia), is the optimal dose for the treatment of men with male pattern hair loss. Arch Dermatol 1999 135 : 989 90.
7. Roberts JL. Finasteride in a 1-mg dose is safe and effective. Arch Dermatol 1999 135 : 990.
8. Tosti A, Camacho-Martínez F, Dawber R. Management of androgenetic alopecia. J Eur Acad Dermatol Venereol 1999 12 : 205 14.
9. Tosti A, Piraccini BM. Finasteride and the hair cycle. Arch Dermatol 2000 43 : 848 9.
10. Whiting DA. Advances in the treatment of male androgenetic alopecia. A brief review of finasteride studies. Eur J Dermatol 2001 11 : 332 4.
11. Frankel S. Study of the Food and Drug Administration files on Propecia: dosages, side effects, and recommendations. Arch Dermatol 1999 135 : 257 8.
12. Camacho F, Montagna W. Current concept and classification. Male androgenetic alopecia. In : Trichology. Diseases of the Pilosebaceous Follicle (Camacho F, Montagna W, eds). Madrid : Aula Médica Ed, 1997 325 42.